Work

Erratum to: Scope and relevance of a pulmonary biopharmaceutical classification system AAPS/FDA/USP Workshop March 16-17th, 2015 in Baltimore, MD

Year: 2016

Type: erratum

Source: AAPS Open

DOI: 10.1186/s41120-016-0005-2

Authors: Jayne E. Hastedt, Per Bäckman, Andrew R. Clark, William Doub, Anthony Hickey, Guenther Hochhaus, Phil J. Kuehl, Claus-Michael Lehr, Peter Mauser, Jason McConville, Ralph Niven, Masahiro Sakagami, Jeffry G. Weers

Institutions: AstraZeneca (United Kingdom), United States Food and Drug Administration, RTI International, University of Florida, Lovelace Respiratory Research Institute, Helmholtz Institute for Pharmaceutical Research Saarland, Saarland University, Merck & Co., Inc., Rahway, NJ, USA (United States), University of New Mexico, Novartis (Switzerland), Virginia Commonwealth University

Language: English

Topic: Inhalation and Respiratory Drug Delivery

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $2,090

OpenAlex ID: W4245529857

Cites: 1

Cited by: 12

Related to: 10